Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps

被引:121
|
作者
Kohanski, Michael A. [1 ]
Workman, Alan D. [1 ]
Patel, Neil N. [1 ]
Hung, Li -Yin [2 ]
Shtraks, Julie P. [3 ]
Chen, Bei [1 ,4 ]
Blasetti, Marie [1 ]
Doghramji, Laurel [1 ]
Kennedy, David W. [1 ]
Adappa, Nithin D. [1 ]
Palmer, James N. [1 ]
Herbert, De'Broski R. [2 ]
Cohen, Noam A. [1 ,2 ,5 ]
机构
[1] Univ Penn, Perelman Sch Med, Div Rhinol, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
[3] Temple Univ, Lewis Katz Sch Med, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19122 USA
[4] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA
[5] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
IL-25; IL-13; solitary chemosensory cells; chronic rhinosinusitis with nasal polyps; type; 2; inflammation; gustducin; doublecortin-like kinase 1; INTERLEUKIN; 33; TUFT CELLS; INFLAMMATION; IMMUNITY; DIFFERENTIATION; EPIDEMIOLOGY; EXPRESSION; CYTOKINES; IL-13;
D O I
10.1016/j.jaci.2018.03.019
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: IL-25 can function as an early signal for the respiratory type 2 response characteristic of allergic asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). In the mouse gut, tuft cells are the epithelial source of IL-25. However, the source of human airway epithelial IL-25 has remained elusive. Objective: In this study we sought to determine whether the solitary chemosensory cell (SCC) is the predominant source of IL-25 in the sinonasal epithelium. Method: Flow cytometry and immunofluorescence for SCCs and IL-25 were used to interrogate polyp and turbinate tissue from patients with CRSwNP. Mucus was collected during acute inflammatory exacerbations from patients with CRSwNP or chronic rhinosinusitis without nasal polyps and IL-25 levels determined by using ELISA. Lastly, sinonasal epithelial cultures derived from polyp and turbinate tissue were stimulated with IL-13 and analyzed for SCC proliferation and IL-25 production. Results: This study demonstrates that a discrete cell type, likely an SCC, characterized by expression of the taste-associated G protein gustducin and the intestinal tuft cell marker doublecortin-like kinase 1, is the predominant source of IL-25 in the human upper airway. Additionally, we show that patients with CRSwNP have increased numbers of SCCs in nasal polyp tissue and that in vitro IL-13 exposure both increased proliferation and induced apical secretion of IL-25 into the mucosal layer. Conclusions: Inflammatory sinus polyps but not adjacent turbinate tissue show expansion of the SCC population, which is the source of epithelial IL-25.
引用
收藏
页码:460 / +
页数:17
相关论文
共 50 条
  • [1] IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis
    Shin, Hyun-Woo
    Kim, Dong-Kyu
    Park, Min-Hyun
    Eun, Kyoung Mi
    Lee, Mingyu
    So, Daeho
    Kong, Il Gyu
    Mo, Ji-Hun
    Yang, Min-Suk
    Jin, Hong Ryul
    Park, Jong-Wan
    Kim, Dae Woo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (06) : 1476 - +
  • [2] Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps
    Lee, Mingyu
    Kim, Dae Woo
    Shin, Hyun-Woo
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 17 (01) : 17 - 22
  • [3] Nasal IL-25 predicts the response to oral corticosteroids in chronic rhinosinusitis with nasal polyps
    Hong, Haiyu
    Chen, Fenghong
    Sun, Yueqi
    Yang, Qintai
    Gao, Wenxiang
    Cao, Yujie
    Fan, Yunping
    Shi, Jianbo
    Li, Huabin
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (05) : 1890 - +
  • [4] The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps
    Ozturan, Atakan
    Eyigor, Hulya
    Eyigor, Mete
    Osma, Ustun
    Yilmaz, Mustafa Deniz
    Selcuk, Omer Tarik
    Renda, Levent
    Gultekin, Meral
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2017, 274 (01) : 283 - 288
  • [5] The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps
    Atakan Ozturan
    Hulya Eyigor
    Mete Eyigor
    Ustun Osma
    Mustafa Deniz Yilmaz
    Omer Tarik Selcuk
    Levent Renda
    Meral Gultekin
    European Archives of Oto-Rhino-Laryngology, 2017, 274 : 283 - 288
  • [6] Nasal IL-25 predicts the response to oral-corticosteroid in chronic rhinosinusitis with nasal polyps (CRSwNP)
    Hong, H.
    Chen, F.
    Sun, Y.
    Fan, Y.
    Shi, J.
    Li, H.
    ALLERGY, 2018, 73 : 248 - 249
  • [7] Hypomethylation of the IL8 promoter in nasal epithelial cells of patients with chronic rhinosinusitis with nasal polyps
    Li, Jingyun
    Jiao, Jian
    Wang, Ming
    Gao, Yunbo
    Li, Ying
    Wang, Yang
    Zhang, Yuan
    Wang, Xiangdong
    Zhang, Luo
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2019, 144 (04) : 993 - +
  • [8] Solitary chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps
    Patel, Neil N.
    Kohanski, Michael A.
    Maina, Ivy W.
    Triantafillou, Vasiliki
    Workman, Alan D.
    Tong, Charles C. L.
    Kuan, Edward C.
    Bosso, John V.
    Adappa, Nithin D.
    Palmer, James N.
    Herbert, De'Broski R.
    Cohen, Noam A.
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (08) : 900 - 906
  • [9] IL-25R-expressing B cells in chronic rhinosinusitis with nasal polyps
    Abdu, S.
    Xia, J.
    Hopkins, C.
    Mckenzie, A.
    Woszczek, G.
    Till, S.
    ALLERGY, 2020, 75 : 499 - 500
  • [10] Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois
    Ogasawara, Noriko
    Klingler, Aiko I.
    Tan, Bruce K.
    Poposki, Julie A.
    Hulse, Kathryn E.
    Stevens, Whitney W.
    Peters, Anju T.
    Grammer, Leslie C.
    Welch, Kevin C.
    Smith, Stephanie S.
    Conley, David B.
    Kern, Robert C.
    Schleimer, Robert P.
    Kato, Atsushi
    ALLERGY, 2018, 73 (11) : 2251 - 2254